242 related articles for article (PubMed ID: 22380870)
1. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
[TBL] [Abstract][Full Text] [Related]
2. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
3. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
[TBL] [Abstract][Full Text] [Related]
4. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
[TBL] [Abstract][Full Text] [Related]
5. Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia.
Lin S; Sun L; Hu J; Wan S; Zhao R; Yuan S; Zhang L
Cancer Lett; 2009 Jun; 279(1):108-17. PubMed ID: 19231068
[TBL] [Abstract][Full Text] [Related]
6. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
7. Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.
Aldinucci D; Lorenzon D; Cattaruzza L; Pinto A; Gloghini A; Carbone A; Colombatti A
Int J Cancer; 2008 Feb; 122(4):769-76. PubMed ID: 17935139
[TBL] [Abstract][Full Text] [Related]
8. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
[TBL] [Abstract][Full Text] [Related]
9. CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation.
Murooka TT; Rahbar R; Fish EN
Biochem Biophys Res Commun; 2009 Sep; 387(2):381-6. PubMed ID: 19607806
[TBL] [Abstract][Full Text] [Related]
10. CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.
Singh SK; Mishra MK; Eltoum IA; Bae S; Lillard JW; Singh R
Sci Rep; 2018 Jan; 8(1):1323. PubMed ID: 29358632
[TBL] [Abstract][Full Text] [Related]
11. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
12. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
[TBL] [Abstract][Full Text] [Related]
13.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated CC receptor/ligand in monocytes/macrophages from tongue squamous cell carcinoma patients is partially rectified by interferon α-2b.
Chakraborty K; Bose A; Goswami KK; Mukherjee KK; Goswami S; Ghosh D; Chakraborty T; Sarkar K; Pal S; Bhowmick A; Biswas J; Baral R
Hum Immunol; 2012 Jan; 73(1):38-47. PubMed ID: 22085486
[TBL] [Abstract][Full Text] [Related]
15. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Vaday GG; Peehl DM; Kadam PA; Lawrence DM
Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
[TBL] [Abstract][Full Text] [Related]
16. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskór BM; Borowik-Zaręba A; Ławicki S
Acta Biochim Pol; 2020 Nov; 67(4):539-449. PubMed ID: 33245226
[TBL] [Abstract][Full Text] [Related]
17. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts.
Tang CH; Hsu CJ; Fong YC
Arthritis Rheum; 2010 Dec; 62(12):3615-24. PubMed ID: 20862675
[TBL] [Abstract][Full Text] [Related]
18. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.
Gao D; Rahbar R; Fish EN
Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323
[TBL] [Abstract][Full Text] [Related]
19. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
20. CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma.
Wang SW; Wu HH; Liu SC; Wang PC; Ou WC; Chou WY; Shen YS; Tang CH
PLoS One; 2012; 7(4):e35101. PubMed ID: 22506069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
